Seah T G, Lew T W, Chin N M
Department of Anaesthesia, Tan Tock Seng Hospital, Singapore.
Ann Acad Med Singap. 1998 May;27(3):442-3.
An unusual cause of "hyperkalaemia" was observed in a neurosurgical patient admitted to our intensive care unit. The cause of the hyperkalaemia was not known initially and treatment with cation ion exchange resin was initiated to lower the elevated serum potassium level. The concurrent occurrence of thrombocytosis and hyperkalaemia raised the possibility of psuedohyperkalaemia associated with thrombocytosis. Simultaneous measurement of plasma and serum potassium with the Hitachi 917 Analyzer (indirect ion selective electrode, coefficient of variation = 1% to 2%) confirmed the diagnosis. Correlation between thrombocytosis and pseudohyperkalaemia was found to be highly significant (r = 0.54; P = 0.014). It is estimated that for for every 100 x 10(9)/L of platelets, an increase of 0.07 to 0.15 mmol/L of potassium is expected. In thrombocytosis, plasma rather than serum potassium should be measured.
在入住我们重症监护病房的一名神经外科患者中观察到一种不寻常的“高钾血症”病因。起初高钾血症的病因不明,遂开始使用阳离子交换树脂进行治疗以降低升高的血清钾水平。血小板增多症与高钾血症同时出现增加了与血小板增多症相关的假性高钾血症的可能性。使用日立917分析仪(间接离子选择电极,变异系数=1%至2%)同时测定血浆和血清钾确诊了该病。发现血小板增多症与假性高钾血症之间的相关性非常显著(r = 0.54;P = 0.014)。据估计,每100×10⁹/L血小板,血钾预计升高0.07至0.15 mmol/L。对于血小板增多症患者,应测定血浆而非血清钾。